iBio (IBIO) EPS (Basic) (2016 - 2025)
Historic EPS (Basic) for iBio (IBIO) over the last 17 years, with Q4 2025 value amounting to -$0.09.
- iBio's EPS (Basic) rose 8125.0% to -$0.09 in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.0, marking a year-over-year decrease of 4925.37%. This contributed to the annual value of -$1.75 for FY2025, which is 2914.6% up from last year.
- Per iBio's latest filing, its EPS (Basic) stood at -$0.09 for Q4 2025, which was up 8125.0% from -$0.11 recorded in Q3 2025.
- iBio's EPS (Basic)'s 5-year high stood at $0.01 during Q2 2021, with a 5-year trough of -$68.43 in Q4 2022.
- Over the past 5 years, iBio's median EPS (Basic) value was -$1.02 (recorded in 2024), while the average stood at -$5.11.
- In the last 5 years, iBio's EPS (Basic) surged by 11135.92% in 2021 and then tumbled by 3010365.36% in 2022.
- iBio's EPS (Basic) (Quarter) stood at -$1.37 in 2021, then crashed by 4894.89% to -$68.43 in 2022, then surged by 93.54% to -$4.42 in 2023, then soared by 89.14% to -$0.48 in 2024, then skyrocketed by 81.25% to -$0.09 in 2025.
- Its EPS (Basic) was -$0.09 in Q4 2025, compared to -$0.11 in Q3 2025 and -$0.49 in Q2 2025.